CompoAtlas

Silhouette légère

Food supplement declared in France, decision dated 26 February 2026

Silhouette légère (PHYSIOMINS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food). 6 rules of use apply to its ingredients (limits and warnings).

Brand
PHYSIOMINS
Food business operator placing the product on the market
NOVI (NOVI)
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Flacon
Daily dose
30 ml par jour
Directions for use
Se consomme pur. Agiter avant utilisation. Prendre une cuillerée à soupe (soit une dose de 15 ml), 15 minutes avant les principaux repas.
Intended populations
Population générale, Hommes et femmes de 18 ans et plus
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Allergie aux dérivés salicylés, À prendre en dehors des repas, Femmes enceintes, Hypertension, Insuffisance rénale, Problèmes cardiaques, Problèmes de foie, Sous anticoagulants, Sous traitement médicamenteux, Sous traitement pour la thyroïde, Ulcère (estomac ou duodenum)
Objectives stated by the manufacturer (these are not authorised claims)
Transit, Détoxifiant / Draineur, Digestion, Gestion du poids / minceur, Minceur / Ventre plat

Declaration 350740, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Camellia sinensis (L.) KuntzeFeuilleExtrait sec aqueux1,800 mg
Achillea millefolium L.Parties aériennesExtrait sec aqueux16.5 mg
Arctium lappa L.RacineExtrait sec aqueux16.5 mg
Borago officinalis L.FleurExtrait sec aqueux16.5 mg
Calluna vulgaris (L.) HullSommités fleuriesExtrait sec aqueux16.5 mg
Carum carvi L.FruitExtrait sec aqueux16.5 mg
Elymus repens (L.) GouldRhizomeExtrait sec aqueux16.5 mg
Filipendula ulmaria (L.) Maxim.Sommités fleuriesExtrait sec aqueux16.5 mg
Foeniculum vulgare Mill.FruitExtrait sec aqueux16.5 mg
Fraxinus excelsior L.FeuilleExtrait sec aqueux16.5 mg
Hieracium pilosella L.Parties aériennesExtrait sec aqueux16.5 mg
Ilex paraguariensis A. St.-Hil.FeuilleExtrait sec aqueux16.5 mg
Levisticum officinale W.D.J. KochRacineExtrait sec aqueux16.5 mg
Nasturtium officinale R.Br.Parties aériennesExtrait sec aqueux16.5 mg
Orthosiphon aristatus (Blume) Miq.FeuilleExtrait sec aqueux16.5 mg
Petroselinum crispum (Mill.) FussFeuilleExtrait sec aqueux16.5 mg
Prunus cerasus L.PédonculeExtrait sec aqueux16.5 mg
Ribes nigrum L.FeuilleExtrait sec aqueux16.5 mg
Rosa canina L.FruitExtrait sec aqueux16.5 mg
Salvia officinalis L.FeuilleExtrait sec aqueux16.5 mg
Taraxacum campylodes G.E.HaglundFeuilleExtrait sec aqueux16.5 mg
Tilia cordata Mill.AubierExtrait sec aqueux16.5 mg
Urtica dioica L.FeuilleExtrait sec aqueux16.5 mg
Viola tricolor L.Parties aériennesExtrait sec aqueux16.5 mg
Zea mays L.StigmatesExtrait sec aqueux16.5 mg
Raphanus sativus L.RacineExtrait sec aqueux0.3 mg

Additives

E422, E330, E202, E211

Other ingredients

Eau potable

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ce produit ne doit pas se substituer à une alimentation diversifiée et équilibrée, et à un mode de vie sain. Respecter les conseils d’utilisation, la dose journalière conseillée et la date limite d’utilisation. Une consommation excessive peut avoir des effets laxatifs. Contient de la caféine (72 mg pour 30 ml) et des épigallocatechine gallate (EGCG) (90 mg pour 30 ml). Ne pas consommer une quantité égale ou supérieure à 800 mg d’EGCG par jour. Ce produit ne doit pas être consommé si vous prenez le même jour d’autres produits contenant du thé vert, ni à jeun, ni par les femmes enceintes ou allaitantes et par les enfants de moins de 18 ans. Déconseillé en cas d'insuffisance cardiaque ou rénale œdémateuses ou sévère. Déconseillé en cas d'ulcère gastroduodénal, d'hypertension artérielle, d'hyperthyroïdie, d'obstruction biliaire, d'insuffisance hépatique ou d'achlorhydrie. Déconseillé en cas d'allergie croisée connue, en particulier aux plantes de la famille des Asteraceae, des Apiaceae (fenouil, céleri, anis, coriandre), au pollen d'armoise, au pollen de bouleau, à l'absinthe ou à l'anéthole. Déconseillé aux personnes souffrant d'hypersensibilité ou d’allergie aux dérivés salicylés et sous traitement anti-coagulant. En cas d'hypothyroïdie, de traitement de la thyroïde ou médicamenteux, consulter préalablement un professionnel de santé. Réserve aux adultes. Tenir hors de portée des jeunes enfants. À conserver dans un endroit sec et frais.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Arctium lappa L.
    Read the warning, when it applies and the studies cited

    Burdock - Arctium Lappa - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

    BURDOCK - ARCTIUM LAPPA - Topical

    Cautions and warnings

    For external use only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

  • Borago officinalis L.
    Read the warning, when it applies and the studies cited
  • Carum carvi L.
    Read the warning, when it applies and the studies cited

    Caraway - Carum Carvi

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen (ESCOP 2003).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have acute abdominal pain (ESCOP 2003).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 31 January 2025

  • Foeniculum vulgare Mill.
    Read the warning, when it applies and the studies cited

    BITTER FENNEL- FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil and Tincture.

    Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

    SWEET FENNEL -FOENICULUM VULGARE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2024).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • Salvia officinalis L.
    Read the warning, when it applies and the studies cited

    SAGE - SALVIA OFFICINALIS - Buccal

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    SAGE -SALVIA OFFICINALIS Oral

    Cautions and warnings

    Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 10 January 2025

  • Taraxacum campylodes G.E.Haglund
    Read the warning, when it applies and the studies cited

    DANDELION - TARAXACUM OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder or an intestinal obstruction (Brinker 2010; Godfrey et al. 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Constipation, Flushing of the urinary tract, Indigestion, and Loss of appetite.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Applies to products providing 10 g or more of dried leaf or dried root or dried whole plant, per day or 10 mL or more of juice, per day.

    Do not use if you have diabetes or a blood pressure, kidney or cardiovascular disorder (Goksu et al. 2010; EMA 2009; Hunt et al. 2005; Green et al. 2002; Mujais and Katz 2000; Carlsen et al. 1990; Kuller et al. 1986; Artz et al. 1966).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications or other products containing diuretics (Goksu et al. 2010; EMA 2009; Hunt et al. 2005; Green et al. 2002; Mujais and Katz 2000; Carlsen et al. 1990; Kuller et al. 1986; Artz et al. 1966).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

  • Tilia cordata Mill.
    Read the warning, when it applies and the studies cited

    Linden - TILIA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Urtica dioica L.
    Read the warning, when it applies and the studies cited

    STINGING NETTLE JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except nutritive tonics.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products except those making only a diuretic claim*.

    When using this product diuretic effect may occur.

    *Note: This statement can be removed from the label if a diuretic claim is included.

    Health Canada monograph dated 27 March 2026

    STINGING NETTLE - URTICA DIOICA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except nutritive tonics.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    All products except those making only a diuretic claim*

    When using this product diuretic effect may occur.

    *Note: This statement can be removed from the label if a diuretic claim is included.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : PHYSIOMINS

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line